The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ANAPTYSBIO INC COM 032724106 3,803 176,894 SH   DFND   0 176,894 0
BIGCOMMERCE HLDGS INC COM SER 1 08975P108 1,546 24,094 SH   DFND   0 24,094 0
IDEAYA BIOSCIENCES INC COM 45166A102 213 15,234 SH   DFND   0 15,234 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 47,665 1,573,357 SH   DFND   1,573,357 0 0
PHATHOM PHARMACEUTICALS INC COM 71722W107 11,990 360,939 SH   DFND   360,939 0 0
PROGYNY INC COM 74340E103 57 1,338 SH   DFND   0 1,338 0
THE REALREAL INC COM 88339P101 11,737 600,664 SH   DFND   600,664 0 0